Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ruvolo

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
Preclinical and early clinical evaluation of the oral AKT inhibitor, MK-2206, for the treatment of acute myelogenous leukemiaMarina Y Konopleva, Roland B Walter, Stefan H Faderl, et al.
Cancer Cell|November 14, 2006
Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemiaMarina Konopleva, Rooha Contractor, Twee Tsao, et al.
Cancer Discovery|December 19, 2013
Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemiaRongqing Pan, Leah J Hogdal, Juliana M Benito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2016
Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung CancersKatrien Van Roosbroeck, Francesca Fanini, Tetsuro Setoyama, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
Preclinical and early clinical evaluation of the oral AKT inhibitor, MK-2206, for the treatment of acute myelogenous leukemiaMarina Y Konopleva, Roland B Walter, Stefan H Faderl, et al.
Cancer Cell|November 14, 2006
Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemiaMarina Konopleva, Rooha Contractor, Twee Tsao, et al.
Cancer Discovery|December 19, 2013
Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemiaRongqing Pan, Leah J Hogdal, Juliana M Benito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2016
Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung CancersKatrien Van Roosbroeck, Francesca Fanini, Tetsuro Setoyama, et al.
Pageof 9